Phase II trial of methylene dimethane sulphonate (MDMS) in advanced soft tissue sarcomas of the adult. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
Steward
W P
WP
Christie Hospital, Manchester, U.K.
Mouridsen
H T
HT
Kerbrat
P
P
Somers
R
R
Verweij
J
J
Van Oosterom
A T
AT
Blackledge
G
G
Havsteen
H
H
Thomas
D
D
Sylvester
R
R
D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008741:Methyl Methanesulfonate / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D012509:Sarcoma / Q000188:drug therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*
D000477:Alkylating Agents; C002538:methylene dimethanesulfonate; D008741:Methyl Methanesulfonate